CA2167362A1 - Apparatus and method for conducting a binding assay on an absorbent carrier material - Google Patents
Apparatus and method for conducting a binding assay on an absorbent carrier materialInfo
- Publication number
- CA2167362A1 CA2167362A1 CA002167362A CA2167362A CA2167362A1 CA 2167362 A1 CA2167362 A1 CA 2167362A1 CA 002167362 A CA002167362 A CA 002167362A CA 2167362 A CA2167362 A CA 2167362A CA 2167362 A1 CA2167362 A1 CA 2167362A1
- Authority
- CA
- Canada
- Prior art keywords
- absorbent material
- reagent
- liquid
- flow
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
Abstract
Improved apparatus for conducting a binding assay comprises:
(a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
(a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
Description
~1673~
The invention relates to an apparatus and a method for carrying out binding assays.
The invention also relates in particular to assays which utilize porous carrier materials for transporting reagents.
Specific binding assays are valuable tools useful in numerous applications. Such assays involve two or more binding components, one of which is analyte. h~mples of specific binding components include antibody and antigen, DNA and/or RNA hybridization, and receptor-ligand interaction. Numerous specific bin~ling assays formats are known in the 0 art, and include competition, sandwich, and agglutination assays.
Unfortunately, specific binding is not always observable. Accordingly, labeling techniques have been developed to make the binding either indirectly or directly observable. Labeling typically involves attaching a detect~hle label to one or both binding components.
~5 Radioisotopes, fluorophores, and enzymes are examples of "indirect"
labels, since they require instrumentation and/or special treatment for detection. In contrast, "direct" labels are visible to the naked eye and do not require special procedures or instrumentation for detection. Metallic sols, dye sols and colored latex are examples of "direct" labels.
a~ Recently, a technology combining binding assay methods and porous carrier materials has been developed. One component of the bintling pair (for example, antibody or antigen), is immobilized onto the porous carrier material (for ex~mple, a fibrous or porous membrane) by one of the many methods well known in the art, for instance by absorption or covalent linkin~.
For example, in a competition assay, a sample cont~inin~ analyte is typically mixed with a labeled analyte or labeled analyte analog (the reagent) capable of specifically binding with the immobilized component. The mixture is then applied to the porous carrier material. Migration of the 30 mixture, caused by capillary wicking within the porous carrier material, Ve / 18.12.95 ~16736~
The invention relates to an apparatus and a method for carrying out binding assays.
The invention also relates in particular to assays which utilize porous carrier materials for transporting reagents.
Specific binding assays are valuable tools useful in numerous applications. Such assays involve two or more binding components, one of which is analyte. h~mples of specific binding components include antibody and antigen, DNA and/or RNA hybridization, and receptor-ligand interaction. Numerous specific bin~ling assays formats are known in the 0 art, and include competition, sandwich, and agglutination assays.
Unfortunately, specific binding is not always observable. Accordingly, labeling techniques have been developed to make the binding either indirectly or directly observable. Labeling typically involves attaching a detect~hle label to one or both binding components.
~5 Radioisotopes, fluorophores, and enzymes are examples of "indirect"
labels, since they require instrumentation and/or special treatment for detection. In contrast, "direct" labels are visible to the naked eye and do not require special procedures or instrumentation for detection. Metallic sols, dye sols and colored latex are examples of "direct" labels.
a~ Recently, a technology combining binding assay methods and porous carrier materials has been developed. One component of the bintling pair (for example, antibody or antigen), is immobilized onto the porous carrier material (for ex~mple, a fibrous or porous membrane) by one of the many methods well known in the art, for instance by absorption or covalent linkin~.
For example, in a competition assay, a sample cont~inin~ analyte is typically mixed with a labeled analyte or labeled analyte analog (the reagent) capable of specifically binding with the immobilized component. The mixture is then applied to the porous carrier material. Migration of the 30 mixture, caused by capillary wicking within the porous carrier material, Ve / 18.12.95 ~16736~
brings the reagent to a position where it competes for a limited number of binding sites of the immobili~e-l specific bin(lin~ component. A portion of the labeled reagent specifically binds to the immobilized reagent and in turn becomes immobilized. The amount of bound labeled reagent is in inverse 5 proportion to the amount of analyte in the sample.
Excess, unreacted material is removed by w~shin~, for example by applying appropriate volume of an eluant to the porous carrier material.
After w~hinE, the label can be developed and/or measured ("indirect"
label), or visually evaluated ("direct" label). Labeled reagent can also be impregnated into the porous carrier material so that the labeled reagent becomes mobile when moistened. In such a case, the addition of the sample itself may be sufficient to initiate and run the assay.
Deutsch, et al. (U.S. Patent Nos. 4,094,647, 4,235,601 and 4,361,537, the contents of which are herein incorporated by reference) discloses a test 5 device for determining a characteristic of a sample (a specific binding assay) in which reagents are mixed and transported in a transportative strip element (also see Baker, et al., WO 87/02774, published May 7, 1987). In one embodiment, a first specific radiolabeled reagent is impregnated into the strip, and a second reagent is immobilized onto the strip downstream of the ao first reagent via att~chment to microbeads. A sample is applied upstream of the first reagent, and the beginning end of the strip is dipped into an eluant.
Eluant migrating through the strip picks up the sample. The eluant cont~ininE the sample then rehydrates the first reagent, mi~es it with the sample, and transports the sample and first reagent to the second reagent, 25 where a specific binding reaction immobilizes a portion of the radiolabeled reagent. Excess radiolabeled reagent is washed away towards the terminal end of the strip. Alternatively, labeled reagent may be applied directly to the strip body.
United States Patent No.4,938,927 issued to Kelton, et al. (the contents of 30 which are herein incorporated by reference) discloses a rotary fluid manipulator cont~ininE a circular chromatographic membrane divided by fluid blocking means into many fluid passages. Each fluid passage contains a labeled specific binding reagent and an immobilized specific binding reagent. A test specimen is applied onto or nearby the labeled reagent. Then, 35 an eluant is applied at a special location close to the center of the membrane.
The eluant moves within particular passage towards the outer side of the ~1673~
.
Excess, unreacted material is removed by w~shin~, for example by applying appropriate volume of an eluant to the porous carrier material.
After w~hinE, the label can be developed and/or measured ("indirect"
label), or visually evaluated ("direct" label). Labeled reagent can also be impregnated into the porous carrier material so that the labeled reagent becomes mobile when moistened. In such a case, the addition of the sample itself may be sufficient to initiate and run the assay.
Deutsch, et al. (U.S. Patent Nos. 4,094,647, 4,235,601 and 4,361,537, the contents of which are herein incorporated by reference) discloses a test 5 device for determining a characteristic of a sample (a specific binding assay) in which reagents are mixed and transported in a transportative strip element (also see Baker, et al., WO 87/02774, published May 7, 1987). In one embodiment, a first specific radiolabeled reagent is impregnated into the strip, and a second reagent is immobilized onto the strip downstream of the ao first reagent via att~chment to microbeads. A sample is applied upstream of the first reagent, and the beginning end of the strip is dipped into an eluant.
Eluant migrating through the strip picks up the sample. The eluant cont~ininE the sample then rehydrates the first reagent, mi~es it with the sample, and transports the sample and first reagent to the second reagent, 25 where a specific binding reaction immobilizes a portion of the radiolabeled reagent. Excess radiolabeled reagent is washed away towards the terminal end of the strip. Alternatively, labeled reagent may be applied directly to the strip body.
United States Patent No.4,938,927 issued to Kelton, et al. (the contents of 30 which are herein incorporated by reference) discloses a rotary fluid manipulator cont~ininE a circular chromatographic membrane divided by fluid blocking means into many fluid passages. Each fluid passage contains a labeled specific binding reagent and an immobilized specific binding reagent. A test specimen is applied onto or nearby the labeled reagent. Then, 35 an eluant is applied at a special location close to the center of the membrane.
The eluant moves within particular passage towards the outer side of the ~1673~
.
circle by wicking and centrifugal force. The principles of the specific binding assay itself are identical to those described in Deutsch, et al.
United States Patent No. 5,238,662 to Sun, et al. (the contents of which are herein incorporated by reference) relates to an analytical test device for a5 competition assay for particular non-protein antigens, such as antigens representing drugs of abuse. Colored latex particles sensitized with detecting antibodies for the non-protein antigen are applied directly to the chromatographic membrane in such a way that latex spheres are immobile when dry and mobile when contacted with liquid. Downstre~m of the latex, the membrane is impregnated with a perm~nently immobile drug conjugate probe. When a sample such as body fluid is applied to the membrane, the latex particles are resuspended by the sample and migrate towards the conjugate. If drugs or their metabolites are present in the s~mple, binding to antibody on the latex will occur during this migration. If the ~mount of drug 5 or drug metabolite is sufficient to exhaust all antibody binding sites, binding of the colored latex particles to the drug conjugate probe will be l.~evented. If there are no drugs or drug metabolites in the sample, then colored latex particles will bind to drug conjugate producing a distinct colored band.
United Kingdom Patent No. 0 291 194 B1, to May, et al., discloses an ao analytical test device comprising a hollow casing containing a chromatographic porous membrane. The device also contains labeled (for example, colored latex) specific binding reagent for an analyte, and an unlabeled specific reagent for the same analyte, permanently immobilized on the membrane. The liquid sample permeates the membrane by capillary 2~; action, picking up the labeled reagent and migrating to the zone with the unlabeled specific reagent. The presence of an analyte within the sample is determined by the extent of labeled reagent binding using either a sandwich or a competition format.
To minimi7e undesirable interactions between the labeled reagent and 30 the membrane, which may cause irreversible sti~ king of the labeled reagent to the membrane, it was suggested to apply the labeled reagent as a surface layer. To achieve this, a glazing material, such as aqueous sucrose or cellulose, is applied prior to the application of the labeled reagent to form a glaze layer. The labeled reagent is then applied on top of the glaze. In 35 practice, however, the gl~7ing material penetrates to some extent into the thickness of the membrane, as does the labeled reagent.
~1673~
United States Patent No. 5,238,662 to Sun, et al. (the contents of which are herein incorporated by reference) relates to an analytical test device for a5 competition assay for particular non-protein antigens, such as antigens representing drugs of abuse. Colored latex particles sensitized with detecting antibodies for the non-protein antigen are applied directly to the chromatographic membrane in such a way that latex spheres are immobile when dry and mobile when contacted with liquid. Downstre~m of the latex, the membrane is impregnated with a perm~nently immobile drug conjugate probe. When a sample such as body fluid is applied to the membrane, the latex particles are resuspended by the sample and migrate towards the conjugate. If drugs or their metabolites are present in the s~mple, binding to antibody on the latex will occur during this migration. If the ~mount of drug 5 or drug metabolite is sufficient to exhaust all antibody binding sites, binding of the colored latex particles to the drug conjugate probe will be l.~evented. If there are no drugs or drug metabolites in the sample, then colored latex particles will bind to drug conjugate producing a distinct colored band.
United Kingdom Patent No. 0 291 194 B1, to May, et al., discloses an ao analytical test device comprising a hollow casing containing a chromatographic porous membrane. The device also contains labeled (for example, colored latex) specific binding reagent for an analyte, and an unlabeled specific reagent for the same analyte, permanently immobilized on the membrane. The liquid sample permeates the membrane by capillary 2~; action, picking up the labeled reagent and migrating to the zone with the unlabeled specific reagent. The presence of an analyte within the sample is determined by the extent of labeled reagent binding using either a sandwich or a competition format.
To minimi7e undesirable interactions between the labeled reagent and 30 the membrane, which may cause irreversible sti~ king of the labeled reagent to the membrane, it was suggested to apply the labeled reagent as a surface layer. To achieve this, a glazing material, such as aqueous sucrose or cellulose, is applied prior to the application of the labeled reagent to form a glaze layer. The labeled reagent is then applied on top of the glaze. In 35 practice, however, the gl~7ing material penetrates to some extent into the thickness of the membrane, as does the labeled reagent.
~1673~
United States Patent No. 5,275,785, to May, et al., ("May '785", the contents of which are herein incorporated by reference) discloses a chromatographic test device incorporating multiple liquid conductive membranes of different wicking ability and a liquid-swellable "switch"
5 material to regulate liquid flow. Different liquid migration speeds in the separate membranes in combination with the liquid-swellable "switch"
material (which establishes or breaks contact between the membranes) allow for del*ery of reagents to the detection zone in a certain order and/or proportion.
lD Unfortunately, the known technologies referred to above, suffer numerous disadvantages. Two problems of particular concern deal with mobilizing dry binding reagents: the first relates to quantity of reagents mobilized, the second to the fashion of mobilization. Although a goal is to mobilize reagents quantitatively, this is often not possible in practice because~5 reagents tend to i~eve~sibly stick to the porous material.
It is preferred to uniformly mobilize reagents to form a continuum with no or minim~l concentration gradient. Such a continuum favors a uniform degree of binding (especially critical for the competition assays), and prepossesses a reproducible uniform result band. One known way to achieve 20 mobilization and a uniform concentration throughout solution of the reagents is to premix a sample and a liquid binfling reagent, for instance labeled binding reagent, and then apply the mixture to a test device, either directly or via a mediating sample pad. Regrettably, however, this multistep procedure is predisposed to experimental error and increases handling of 25 potentially hazardous samples.
One-step devices require only the single step of adding sample to perform a test. The binding reagent is usually embedded into an absorbent material which is in serial contact with the porous carrier material or directly applied to the porous carrier material. However, in such cases the 30 liquid front of a sample non-uniformly mobilizes the dry impregnated binding reagent so that the reagent concentration is highest at the front, thus resulting in a non-uniform concentration pattern which is very sensitive to any variation in the porous carrier material. Even small lot-to-lotdifferences can cause an adverse affect and precise titration of the labeled ~5 reagent is required. Since the titer is chosen with respect to performance at ~1673~2 cutoff level of an analyte, it is often difficult to achieve substantial differentiation between no analyte and analyte-at-cutoff ~ign~
Other disadvantages of known one-step systems are non-uniform migration of labeled bin~ing reagent and poor rehydration of latex. The prior 5 art attempted to overcome the problem of poor rehydration and i~leve~sible sticking of latex by applying a binding reagent to the surface layer on top of gl~ing material (see for example, May, et al., discussed above). However, the viscous compounds which form the gl~7:in~ material deteriorate migration and cause eddies. This leads to poor reproducibility and a broken result band. In a competitive format, the disadvantages are more acute than in a sandwich assay format.
The object of the invention therefore is to provide an assaying device which makes possible to overcome the above-mentioned problems.
An assaying device according to the invention is characterized in that it comprises (a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
The main advantages of the closure according to the invention are as follows:
The subject invention overcomes the above-mentioned problems and provides an improved specific binding assay through the use of an additional 30 top membrane (a porous carrier material) which contains a specific binding reagent. Through an additional independent membrane impregnated with specific binding reagent, rehydration of the specific reagent and the extent of its dilution by the sample is controlled thereby optimi7ing the performance of the assay. This unique design achieves a more uniform migration pattern of ~1ii73~2 the labeled reagent, and elimin~tes undesirable flooding of the membrane body when e~cessive sample volume is applied.
The subject invention can be used with, but is not limited to, use with an assaying device for conducting specific binding assays, in particular drug of 5 abuse assays. Such an assaying device is configured and ~limen~ioned to incorporate porous carrier material test strips. A device of this type is disclosed by European Patent Application with publication No. EP-A-0668745, the contents of which are hereby incorporated by reference.
In an assaying device according to the invention the first absorbent material and the second absorbent material are preferably composed of the same material.
In an assaying device according to the invention the first absorbent material is preferably selected from the group consisting of bibulous membranes and porous membranes. The first absorbent material is 5 preferably nitrocellulose.
In an assaying device according to the invention the second absorbent material is preferably selected from the group consisting of bibulous membranes and porous membranes. The second absorbent material is preferably nitrocellulose.
ao In a preferred embodiment of an assaying device according to the invention the first absorbent material and the second absorbent material are held in contact with each other by a holder, the holder being preferably a band of material, said band of material being preferably a polyester film.
In a preferred embodiment of an assaying device according to the 25 invention the second reagent is labeled, the label being preferably a colored latex.
In a preferred embodiment of an assaying device according to the invention the first absorbent material has a plurality of reagents immobilized thereon.
In a preferred embodiment of an assaying device according to the invention the second absorbent material has a plurality of reagents immobilized thereon.
3 ~ 2 In a preferred embodiment of an assaying device according to the invention the first reagent and the second reagent have an affinity to bind with each other.
In a preferred embodiment of an assaying device according to the invention the first reagent and the second reagent each have an affinity to bind with the same substance.
In a preferred embodiment of an assaying device according to the invention the wicking rate of the first absorbent material is the same or higher than the wicking rate of the second absorbent material.
0 In a further preferred embodiment of an assaying device according to the invention the ~-vicking rate of the first absorbent material is lower than the wicking rate of the second absorbent material.
In a preferred embodiment of an assaying device according to the invention the first reagent is i~eve~sibly immobilized on the first absorbent 5 material.
In a preferred embodiment of an assaying device according to the invention the first absorbent material and the second absorbent material each have planar surfaces. In a particularly preferred embodiment the planar surface of the first absorbent material is juxtaposed to the planar 20 surface of the second absorbent material.
A method for conducting a binding assay according to the invention is characterized in that it comprises:
(a) introducing a liquid sample into a first absorbent material to generate a first flow of liquid within the first absorbent material;
(b) introducing the liquid from the first absorbent material into a second absorbent material to generate a second flow of liquid within the second absorbent material while maint~ining the first flow of liquid within the first absorbent material;
(c) introducing a second reagent into the second flow of liquid within the second absorbent material, the second flow, after the introduction of the second reagent, being in a direction generally parallel to the first flow of liquid within the first absorbent material; and ~1673~
(d) introducing the second flow of liquid and the second reagent from the second absorbent material into the first absorbent material to unite with the first flow of liquid within the first absorbent material.
In a preferred embodiment of a method according to the invention, the first flow of liquid within the first absorbent material flows at the same or greater velocity than the second flow of liquid within the second absorbent material.
In a preferred embodiment of a method according to the invention, the first flow of liquid within the first absorbent material flows at a lesser velocity than the second flow of liquid within the second absorbent material.
An embodiment of the invention will now be described with reference to the accompanying drawings, in which:
FIG. lA depicts a front view of the strip compartment of an assaying 15 device without cover panel.
FIG. lB depicts a side section view of FIG.lA
FIG. lC depicts the cover panel of the assaying device.
FIG. lD depicts a perspective view of the test strip according to the present invention.
ao FIG. 2 depicts a graph of colorimetric density vs. morphine concentration for an assay conducted using the apparatus of the present invention.
FIG. 3 depicts a graph of colorimetric density vs. morphine concentration for an assay conducted using a nitrocellulose onto which 25 reagents had been dispensed using an IVEK Digispense 2000TM system.
FIG. 4 depicts a graph of colorimetric density vs.
Tetrahydroc~nn~binoids (THC) concentration for an assay conducted using the apparatus of the present invention.
FIG. 5 depicts a graph of colorimetric density vs. THC concentration for 30 an assay conducted using a nitrocellulose onto which reagents had been dispersed using an IVEK Digispense 2000TM system.
21673~2 g FIG. 6 depicts a graph of colorimetric density vs. THC concentration for an assay conducted using a nitrocellulose onto which reagents had been sprayed using a Paasche airbrush.
FIG. 7 depicts a graph of colorimetric density vs. THC concentration for 5 an assay conducted on nitrocellulose that had been sucrose glazed.
FIG. 8 depicts a graph of colorimetric density vs. THC concentration for an assay conducted using a glazed nitrocellulose with latex in methyl cellulose solution applied over the sucrose glaze.
The subject invention is described below in terms of its preferred embo-liments. These embodiments are set forth to aid in underst~n(ling the invention, but are not to be construed as limiting.
The apparatus and method of the present invention are particularly well suited for use in testing drugs of abuse, such as cocaine, amphetamines, c~nn~hinoids, barbiturates, benzodiazepines, opiates, 5 phencyclidines, propoxyphine, methaqualone, tricyclic antidepressants and methadone, as well as for clinical chemistry, pregnancy, and simil~r testing.
As used throughout the specification, the terms "membrane," "porous carrier material" and "absorbent material" have been used interchangeably, 20 and are to connote a material suitable for the assays desc~ibed herein.
To aid in understanding the invention, several positional terms have been used. The "top" and "main" membranes have been described with the terms "forward" and "rearward." "Forward" is the portion of a membrane which extends beyond the lengthwise midpoint (located in the direction of 25 liquid flow within the membrane). The most forward portion of a membrane is referred to as the "terminal end." "Rearward" is opposite of forward and relates to the portion of the membrane which precedes the lengthwise midpoint in the direction of the end initially contacted by the liquid sample.
The most rearward portion of the membrane is referred to as the "be inning 30 end." "Downstream" is the direction in which the liquid flows within the membranes. In contrast, "upstream" relates to a direction opposite the flow of liquid within the membrane.
A sample is absorbed at the beeinnin~ end of the main membrane and is transported along the length of the main membrane by capillary action.
216~36~
Generally, membrane length is in the range of 1-10 cm, width 0.4-2 cm, and thickness 0.1-1 mm. Typically, the membrane is shaped as an elongated, thin rectangular prism.
When the s~mple flow reaches the reagent-cont~ining top membrane (generally cont~ining a labeled reagent), it splits into two flows: one continues to run in the main membrane, the second permeates into the top membrane, typically in the rearward portion, and mobilizes the reagent located within the top membrane. The reagent within the top membrane is mobile when in a moist state. Although for clarity a single reagent is o described as being in the top membrane, it should be appreciated that multiple reagents may also be employed. Likewise, a plurality of top membranes each cont,~ining one or more reagents may be utilized.
Preferred labels are colored colloidal particles, and colored latex is most preferred. Colored latex is readily visible to the naked eye when bound in the 5 detection zone, therefore no additional developing procedures are required.
Procedures for sensitization of late2~ with specific bin(ling reagents are well known in the art (for example, see Illum, L. and P.D.E. Jones, Attachm~snt of Monoclonal Antibodies to Microspheres, Methods in EnzYmolo~v. Vol.112.
pages 67-84 (1985)) and Galloway, R.J., Development of Microparticle Tests aD and Immunoassays, Seradyn~ Inc.. pages 6-31(1988)). As alluded to above, multiple reagents may be utilized in one or more top membranes. As such, multiple latex cont~ining membranes or one late~ cont~ining membrane sensitized with a plurality of binding reagents, for example antigens and/or antibodies, may be employed.
The two parallel flows reunite and mix in the main membrane near or at the forward edge of the top membrane. While migration continues towards the detection site within the main membrane, a binding reaction between the reagent and the analyte takes place. The extent of this binding or simply the presence of the analyte, depen-ling on whether the assay is a 30 competition or a sandwich format, is measured at a detection site, where specific binding with the immobilized reagent occurs. Unbound material continues to migrate downstream towards the terminal end of the main membrane and is partially captured at the control site. No unbound labeled reagent rem~in~ in the detection or the control sites.
21673~
On the main membrane there is a detection site where specific bin-ling reagent (generally unlabeled) is immobilized (that is, the immobilized specific bintling reagent cannot be washed away by a developing liquid).
Downstream of the detection site there is a control site, where another 5 binding reagent is immobilized. When assembled, the top membrane is in contact with the upper surface of the main membrane upstream of the detection site (see FIG lD).
Optionally, a sample pad can be used to absorb a liquid sample and release the liquid into the beginning end of the main membrane. The sample pad is typically fashioned from a blotting material, and is in contact with the main membrane. The sample pad may optionally contain additional reagents.
Optionally, a "sink" pad, fashioned from a blotting material, can be used at the terminal end of the main membrane to absorb excess reagent solution and foster c~pill~qry flow in the main membrane for a longer period of time.
The membranes and the pads are preferably disposed in a holder. The use of a sample pad and a sink pad are described in U.S. Patent Nos.
4,966,302 and 5,238,652, the contents of which are herein incorporated by ao reference. A s_illed artisan having read the present specification would be able to use such pads in connection with the present invention.
Examples of suitable top and main membranes include bibulous or fibrous material capable of capillary action, such as thin layer chromatography materials, paper or cellulose chromatography substrates, 25 porous synthetic plastics, etc. Preferred absorbent materials have good wicking ability, a smooth surface which insures good contact between the "main" and "top" membranes, reversible binding of the labeled compound to the membrane to promote quantitative mobilization, ability to transport a labeled reagent by capillary action, availability of wicking characteristics 30 within suitable range, reproducible and convenient reagent application and handling.
Preferred membranes include nitrocellulose and nylon. Moreover, memb-ranes precast on plastic are preferred because of handling convenience. Nitrocellulose is desirable because it (i) is able to bind proteins35 by adsorption without requiring complicated covalent linking, (ii) has ~1673~
excellent wicking characteristics, and (iii) is available in a convenient range of pore sizes. Backed nitrocellulose (for egample, precast on a plastic material), is most preferred. Procedures for adsorption of specific proteins on nitrocellulose to form detection and control sites, and blocking of 6 unoccupied binding sites on the nitrocellulose with neutral blocking reagent are well known in the art (see for example, Harvey, M.A., Optimization of Nitrocellulose Membrane-Based Immunoassays, Schleicher & Schuell. No.
557, pp. 18-23, 1991).
Migration rates vary with membrane properties, for example, pore size.
Selection of flow rate, appropriate membrane type, and pore size is within the knowledge of the skilled artisan, and can be determined with minim~l experimentation.
Because of the fluid dynamics within the top membrane, reagent (typically labeled) tends to concentrate at the forward edge of the top 6 membrane and seep slowly into the main membrane where it mixes with the first flow. The extent of dilution has been postulated to be controlled by flow dynamics in the present invention rather than by the rate of reagent mobili~tion, as in known formats. Thus, the subject invention provides the advantage of relatively constant concentration of the top membrane reagent 20 within the reunited flow which occurs downstream in the main membrane.
This constant concentration of reagent is maintained as long as the reagent supply in the top membrane lasts.
The rate of reagent dilution from the top membrane can be controlled by choosing an appropriate difference in wicking rates between the main 26 membrane and the top membrane. "Wicking rate" refers to the speed of liquid movement within the membrane (distance/time). The top membrane can be made from the same material or other suitable porous carrier material. However, for convenience, the top and the main membranes are generally made from the same material. Such a choice of appropriate 30 membrane materials is readily made by the skilled artisan having read the present specification. For instance, when a higher rate of dilution is required, reagent can be applied via a membrane having slower wicking properties, for example, by using a membrane having a smaller pore size.
The wicking rate for the main membrane is preferably higher than or 35 equal to the wicking rate of the top membrane. As a result, reagent from the ~1~7362 top membrane permeates into the main membrane behind the liquid front in the main membrane, thus allowing the first flow to prewet the main membrane. Prewetting advantageously (i) facilitates uniform migration of the reagent from the top membrane, (ii) elimin~tes or at least significantly reduces negative effect of hydrophobicity due to unlabeled bin(l;ng reagents at the detection site, and (iii) facilitates binding at the detection site.
A labeled binding reagent is normally applied to a membrane which has previously been blocked with a blocking compound in order to avoid non-0 specific binding of a labeled reagent to the membrane surface.
The membrane can be cut and the test strips assembled in any suitablemanner. Alternatively, the membrane may be pre-formed to certain tlimen~ional specifications. For instance, it can be convenient to assemble large segments first by securing the top membrane on the surface of the ~5 main membrane, which is then cut into strips. The top membrane preferably is the same width as the main membrane, or is more narrow.
The length of each membrane is determined empirically, but relatively short membranes with the dimensions just sufficient to accommodate the required amount of a bin-ling reagent are preferred. Exact distance between ~o the membrane and the detection site is determined by balancing the time required for proper mi~ing of the reagents and completion of a bin~inE
reaction, with the deterioration of uniform migration if the distance is too long. Such special parameters can be determined through minim~l experimentation. Presently, a distance in the range from 0.5 cm to 6 cm is 2~ preferred. Position of the top membrane on the main membrane is upstream of the detection site, but downstre~m of the sample application site.
Lamination of the main and top membranes further prevents occasional membrane flooding due to excess sample traveling outside of the 30 membranes. If a flood wave of sample reaches the location where reagent is imbedded, it may completely distort the test result. This problem is particularly acute in the applications where the sample migrates downwards.
(~ontact between the top and main membranes can be achieved in a 35 number of ways. For instance, the main and the top membranes can be ~1~7~
pressed against each other by housing elements, or may be l~min~ted one to another, or both. T~min~tion is preferred because a reliable "tight" contact is achieved. Moreover, the l~min~te acts as a dam to prevent flooding. A
preferred way to m~imi~e contact between the membranes, involves 5 l~min~ting the top membrane over the main membrane in juxtaposition using a polyester film, such as the mylar tape described in the following example.
Currently it is preferred for reagent from the top membrane not to cross the interface between the membranes to any appreciable extent, but rather to 0 be transported completely inside the top membrane towards the forward edge.
Figures lA through lD, depict a specific device which utilizes chromatographic principles to perform specific binding assays. Three porous carrier membranes testing three different analytes are shown in a plastic holder (102). Such a holder may form a portion of an assaying device of the type disclosed by European Patent Application with publication No. EP-A-0668745, the contents of which are herein incorporated by reference.
Typically, plastic holder (102) will retain three to five porous carrier membranes. FIG. lA shows three porous carrier membranes, whereas ao FIG. lC shows windows for five porous carrier membranes.
Main membrane (101) contains detection site (103) and control site (104). Labeled specific binding reagent (105) is embedded in top membrane (106) which contacts the upper surface of main membrane (101). Top membrane (106) is tightly attached to main membrane (101) with a polyester 25 film with adhesive backing, e.g. with adhesive mylar tape (107). Contacting, and preferably slightly overlapping, be~inning end (108) of each main membrane (101) is sample pad (109). Sample contacts sample pad (109) through several small holes in the back side of the pad (not shown). A soft rubber seal (110) sits on the top of sample pad (109). The degree of softness 30 needed is readily determined by the skilled artisan. Seal (110) is somewhat dimensionally larger than s~mple pad (109), so that it covers sample pad (109) and seals it along its borders when squeezed.
Sealing is required to prevent leakage of the sample when the chromatographic membranes are installed vertically (sample migrates in a 35 downwards direction). Of course, a seal (110) can also be used when the ~1~7~
apparatus is used in other than a vertical position. Absorbent pad (111) at the terminal end (112) of the chromatographic membranes is common to all three membranes. Each detection site can be observed through a cross-shaped result window (113) and the corresponding control site through a 5 circular control window (114) of the cover panel (115). The plastic of the cover panel is typically not transparent. The cross-shaped result window labeled with COC is for an assay for the detection of benzoylecgonine in urine. The cross-shaped result window labeled with THC, which stands for Tetrahydroc~nn~binoids, is for an assay for the detection of c~nn~hinoids in ID urine. The cross-shaped result window labeled with MOR is for an assay for the detection of opiates in urine. The appearance of a blue bar in each of the round windows 114 labeled TEST COMPLETE indicates that the corresponding test has run to completion and that the results may be interpreted. These windows 114 expose an area of the membrane strip that is 5 coated with anti-bovine serum albumin antibodies. Late~ microparticles are overcoated with bovine serum albllmin so that when they migrate past this area of the membrane the antibody binds to the bovine serum albumin and captures the microparticle.
The present invention is particularly useful in a competition assay 20 format. In one version of this format, the labeled reagent in the top membrane is either the analyte itself or an analog capable of the same type of specific binding. The labeled reagent is mobilized and diluted by a sample, and migrates with the sample towards the detection site, where unlabeled reagent capable of binding the analyte or its structural analog is 25 immobilized. If analyte is present in a sample, it will compete with the labeled reagent for a limited number of binding sites in the detection zone, and the relative concentration of the analyte can be determined from the extent of reduction of hin~ling of the labeled reagent.
In another version, competition is time resolved. In this case, the 30 labeled reagent is a binding partner of the analyte or of its structural analog.
The labeled reagent is mobilized and diluted by a sample, and then migrates with the sample towards the detection site, where the unlabeled analyte or its analog is immobilized. If analyte is present in the s~mple, then during the course of migration it will bind to the labeled reagent. Rem~ining 35 unsaturated binding sites of the labeled reagent can bind to the immobilized reagent in the detection site. Once again, concentration of the analyte can be determined from the extent of reduction of binding of the labeled reagent.
~1~136~
For both versions of the competition format, the ratio of concentrations of bin~ling components in migrating liquid should not fluctuate significantly over the rlimen~ions of the labeled reagent moving zone. Also, uniformity should not decay over the terrn of migration to the detection site. Deviation in5 flow uniformity allows competition to fluctuate, and leads to poorly reproducible results. The present invention minimi~es non-uniformity, and improves sensitivity by m~king the labeled reagent more dilute (as described below).
Discrimination between zero analyte level and cut-off analyte level can lD be improved by increasing the total amount of labeled reagent and increasing the volume in which it is presented. As a result, analytical signal at zero drug level becomes stronger, while the signal at cut-off level iskept lln~h~nged, the steeper calibration curve allows better discrimin~tion.
The present invention is also useful in a sandwich format. In this format, both the labeled reagent and the unlabeled immobilized reagent are the binding partners of the analyte (though they typically should bind to different epitopes of the analyte). Preferably both the labeled and immobilized unlabeled reagents are present in excess of the analyte. If analyte is present ao in the sample, then during the course of migration it will fully bind to the labeled reagent. In the detection site, analyte, which is already bound to the labeled reagent, will bind to the immobilized reagent, forming the sandwich.
The analyte concentration is directly proportional to the binding at the detection site.
The following e~mple of a morphine assay is provided to illustrate the invention. It must be pointed out, however, that the present invention is not limited to any particular substance.
Morphine derivative - N-[3-[(7,8-Didehydro-4,5-epoxy-6-hydro-17-methyl-30 morphinan-3-yl)oxy]propoxy]-4-isothiocyanatobenzamide- was prepared as described in European Application with publication No. EP-A-0386644.
Conjugation of this morphine derivative to bovine serum albumin (BSA) was performed as follows: To a solution of BSA (approximately 57 mg/mL) 6~
in 50 mM potassium phosphate, pH 8, (438 mL) (cooled in an ice bath), dimethylsulfoxide (DMSO) was added dropwise (188 mL). After warming to 25 C, a 5 mg/mL solution of the above mentioned derivative in DMSO (190 ml) was added dropwise. The reaction mixture was stirred at room 5 temperature for 16 hours and then transferred to dialysis tubing and dialyzed first against 15 volumes of 20% DMSO - potassium phosphate buffer (50 mM, pH 8), second against 10% DMSO - potassium phosphate buffer, and third for four times more against potassium phosphate buffer.
Colored uniform carboxylate-modified styrene microparticles, e.g. blue 0 latex from Seradyn (0.3 micron particles), was first washed three times at 1% solids by centrifuging in 20 mM, pH 6.1 MES (2-[N-morpholino]ethanesulfonic acid). The washed latex was then adjusted to 5%
solids in MES and (i) sensitized with 2 mg/mL anti-morphine monoclonal antibody for 16 hours at room temperature, (ii) blocked with BSA solution in 5 MES for 1 hour at room temperature, then (iii) washed for three times at 1%
solids in MES by centrifugation, and (*) adjusted again to 5% solids. Before use, equal volumes of this lateg and 35% w/v sucrose in MES were mixed.
Large pore size nitrocelullose cast directly on polyester film, e.g. Mylar backed large pore size nitrocellulose (10-20 micron) from Millipore, was cut ~o into pieces of 10 cm in length and 5 cm in width. Solution of morphine-BSA
conjugate (about 5 mg/mL) and anti-BSA monoclonal Ab (about 2 mg/mL), both in 50 mM potassil7m phosphate buffer pH 7.5, were dispensed using a positive displacement liquid dispensing system, e.g. IVEK Corp. Digispense 2000TM system, at the rate 1 ~lVcm onto nitrocellulose at a distance 25 respectively 2 cm and 1 cm from the 10 cm side. Nitrocellulose segments were allowed to dry for about 30 min. at 37C and then were blocked with 1%
w/v polyvinyl alcohol (PVA, m.w. 13,000-23,000) solution in 20 mM Tris, pH
material (which establishes or breaks contact between the membranes) allow for del*ery of reagents to the detection zone in a certain order and/or proportion.
lD Unfortunately, the known technologies referred to above, suffer numerous disadvantages. Two problems of particular concern deal with mobilizing dry binding reagents: the first relates to quantity of reagents mobilized, the second to the fashion of mobilization. Although a goal is to mobilize reagents quantitatively, this is often not possible in practice because~5 reagents tend to i~eve~sibly stick to the porous material.
It is preferred to uniformly mobilize reagents to form a continuum with no or minim~l concentration gradient. Such a continuum favors a uniform degree of binding (especially critical for the competition assays), and prepossesses a reproducible uniform result band. One known way to achieve 20 mobilization and a uniform concentration throughout solution of the reagents is to premix a sample and a liquid binfling reagent, for instance labeled binding reagent, and then apply the mixture to a test device, either directly or via a mediating sample pad. Regrettably, however, this multistep procedure is predisposed to experimental error and increases handling of 25 potentially hazardous samples.
One-step devices require only the single step of adding sample to perform a test. The binding reagent is usually embedded into an absorbent material which is in serial contact with the porous carrier material or directly applied to the porous carrier material. However, in such cases the 30 liquid front of a sample non-uniformly mobilizes the dry impregnated binding reagent so that the reagent concentration is highest at the front, thus resulting in a non-uniform concentration pattern which is very sensitive to any variation in the porous carrier material. Even small lot-to-lotdifferences can cause an adverse affect and precise titration of the labeled ~5 reagent is required. Since the titer is chosen with respect to performance at ~1673~2 cutoff level of an analyte, it is often difficult to achieve substantial differentiation between no analyte and analyte-at-cutoff ~ign~
Other disadvantages of known one-step systems are non-uniform migration of labeled bin~ing reagent and poor rehydration of latex. The prior 5 art attempted to overcome the problem of poor rehydration and i~leve~sible sticking of latex by applying a binding reagent to the surface layer on top of gl~ing material (see for example, May, et al., discussed above). However, the viscous compounds which form the gl~7:in~ material deteriorate migration and cause eddies. This leads to poor reproducibility and a broken result band. In a competitive format, the disadvantages are more acute than in a sandwich assay format.
The object of the invention therefore is to provide an assaying device which makes possible to overcome the above-mentioned problems.
An assaying device according to the invention is characterized in that it comprises (a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
The main advantages of the closure according to the invention are as follows:
The subject invention overcomes the above-mentioned problems and provides an improved specific binding assay through the use of an additional 30 top membrane (a porous carrier material) which contains a specific binding reagent. Through an additional independent membrane impregnated with specific binding reagent, rehydration of the specific reagent and the extent of its dilution by the sample is controlled thereby optimi7ing the performance of the assay. This unique design achieves a more uniform migration pattern of ~1ii73~2 the labeled reagent, and elimin~tes undesirable flooding of the membrane body when e~cessive sample volume is applied.
The subject invention can be used with, but is not limited to, use with an assaying device for conducting specific binding assays, in particular drug of 5 abuse assays. Such an assaying device is configured and ~limen~ioned to incorporate porous carrier material test strips. A device of this type is disclosed by European Patent Application with publication No. EP-A-0668745, the contents of which are hereby incorporated by reference.
In an assaying device according to the invention the first absorbent material and the second absorbent material are preferably composed of the same material.
In an assaying device according to the invention the first absorbent material is preferably selected from the group consisting of bibulous membranes and porous membranes. The first absorbent material is 5 preferably nitrocellulose.
In an assaying device according to the invention the second absorbent material is preferably selected from the group consisting of bibulous membranes and porous membranes. The second absorbent material is preferably nitrocellulose.
ao In a preferred embodiment of an assaying device according to the invention the first absorbent material and the second absorbent material are held in contact with each other by a holder, the holder being preferably a band of material, said band of material being preferably a polyester film.
In a preferred embodiment of an assaying device according to the 25 invention the second reagent is labeled, the label being preferably a colored latex.
In a preferred embodiment of an assaying device according to the invention the first absorbent material has a plurality of reagents immobilized thereon.
In a preferred embodiment of an assaying device according to the invention the second absorbent material has a plurality of reagents immobilized thereon.
3 ~ 2 In a preferred embodiment of an assaying device according to the invention the first reagent and the second reagent have an affinity to bind with each other.
In a preferred embodiment of an assaying device according to the invention the first reagent and the second reagent each have an affinity to bind with the same substance.
In a preferred embodiment of an assaying device according to the invention the wicking rate of the first absorbent material is the same or higher than the wicking rate of the second absorbent material.
0 In a further preferred embodiment of an assaying device according to the invention the ~-vicking rate of the first absorbent material is lower than the wicking rate of the second absorbent material.
In a preferred embodiment of an assaying device according to the invention the first reagent is i~eve~sibly immobilized on the first absorbent 5 material.
In a preferred embodiment of an assaying device according to the invention the first absorbent material and the second absorbent material each have planar surfaces. In a particularly preferred embodiment the planar surface of the first absorbent material is juxtaposed to the planar 20 surface of the second absorbent material.
A method for conducting a binding assay according to the invention is characterized in that it comprises:
(a) introducing a liquid sample into a first absorbent material to generate a first flow of liquid within the first absorbent material;
(b) introducing the liquid from the first absorbent material into a second absorbent material to generate a second flow of liquid within the second absorbent material while maint~ining the first flow of liquid within the first absorbent material;
(c) introducing a second reagent into the second flow of liquid within the second absorbent material, the second flow, after the introduction of the second reagent, being in a direction generally parallel to the first flow of liquid within the first absorbent material; and ~1673~
(d) introducing the second flow of liquid and the second reagent from the second absorbent material into the first absorbent material to unite with the first flow of liquid within the first absorbent material.
In a preferred embodiment of a method according to the invention, the first flow of liquid within the first absorbent material flows at the same or greater velocity than the second flow of liquid within the second absorbent material.
In a preferred embodiment of a method according to the invention, the first flow of liquid within the first absorbent material flows at a lesser velocity than the second flow of liquid within the second absorbent material.
An embodiment of the invention will now be described with reference to the accompanying drawings, in which:
FIG. lA depicts a front view of the strip compartment of an assaying 15 device without cover panel.
FIG. lB depicts a side section view of FIG.lA
FIG. lC depicts the cover panel of the assaying device.
FIG. lD depicts a perspective view of the test strip according to the present invention.
ao FIG. 2 depicts a graph of colorimetric density vs. morphine concentration for an assay conducted using the apparatus of the present invention.
FIG. 3 depicts a graph of colorimetric density vs. morphine concentration for an assay conducted using a nitrocellulose onto which 25 reagents had been dispensed using an IVEK Digispense 2000TM system.
FIG. 4 depicts a graph of colorimetric density vs.
Tetrahydroc~nn~binoids (THC) concentration for an assay conducted using the apparatus of the present invention.
FIG. 5 depicts a graph of colorimetric density vs. THC concentration for 30 an assay conducted using a nitrocellulose onto which reagents had been dispersed using an IVEK Digispense 2000TM system.
21673~2 g FIG. 6 depicts a graph of colorimetric density vs. THC concentration for an assay conducted using a nitrocellulose onto which reagents had been sprayed using a Paasche airbrush.
FIG. 7 depicts a graph of colorimetric density vs. THC concentration for 5 an assay conducted on nitrocellulose that had been sucrose glazed.
FIG. 8 depicts a graph of colorimetric density vs. THC concentration for an assay conducted using a glazed nitrocellulose with latex in methyl cellulose solution applied over the sucrose glaze.
The subject invention is described below in terms of its preferred embo-liments. These embodiments are set forth to aid in underst~n(ling the invention, but are not to be construed as limiting.
The apparatus and method of the present invention are particularly well suited for use in testing drugs of abuse, such as cocaine, amphetamines, c~nn~hinoids, barbiturates, benzodiazepines, opiates, 5 phencyclidines, propoxyphine, methaqualone, tricyclic antidepressants and methadone, as well as for clinical chemistry, pregnancy, and simil~r testing.
As used throughout the specification, the terms "membrane," "porous carrier material" and "absorbent material" have been used interchangeably, 20 and are to connote a material suitable for the assays desc~ibed herein.
To aid in understanding the invention, several positional terms have been used. The "top" and "main" membranes have been described with the terms "forward" and "rearward." "Forward" is the portion of a membrane which extends beyond the lengthwise midpoint (located in the direction of 25 liquid flow within the membrane). The most forward portion of a membrane is referred to as the "terminal end." "Rearward" is opposite of forward and relates to the portion of the membrane which precedes the lengthwise midpoint in the direction of the end initially contacted by the liquid sample.
The most rearward portion of the membrane is referred to as the "be inning 30 end." "Downstream" is the direction in which the liquid flows within the membranes. In contrast, "upstream" relates to a direction opposite the flow of liquid within the membrane.
A sample is absorbed at the beeinnin~ end of the main membrane and is transported along the length of the main membrane by capillary action.
216~36~
Generally, membrane length is in the range of 1-10 cm, width 0.4-2 cm, and thickness 0.1-1 mm. Typically, the membrane is shaped as an elongated, thin rectangular prism.
When the s~mple flow reaches the reagent-cont~ining top membrane (generally cont~ining a labeled reagent), it splits into two flows: one continues to run in the main membrane, the second permeates into the top membrane, typically in the rearward portion, and mobilizes the reagent located within the top membrane. The reagent within the top membrane is mobile when in a moist state. Although for clarity a single reagent is o described as being in the top membrane, it should be appreciated that multiple reagents may also be employed. Likewise, a plurality of top membranes each cont,~ining one or more reagents may be utilized.
Preferred labels are colored colloidal particles, and colored latex is most preferred. Colored latex is readily visible to the naked eye when bound in the 5 detection zone, therefore no additional developing procedures are required.
Procedures for sensitization of late2~ with specific bin(ling reagents are well known in the art (for example, see Illum, L. and P.D.E. Jones, Attachm~snt of Monoclonal Antibodies to Microspheres, Methods in EnzYmolo~v. Vol.112.
pages 67-84 (1985)) and Galloway, R.J., Development of Microparticle Tests aD and Immunoassays, Seradyn~ Inc.. pages 6-31(1988)). As alluded to above, multiple reagents may be utilized in one or more top membranes. As such, multiple latex cont~ining membranes or one late~ cont~ining membrane sensitized with a plurality of binding reagents, for example antigens and/or antibodies, may be employed.
The two parallel flows reunite and mix in the main membrane near or at the forward edge of the top membrane. While migration continues towards the detection site within the main membrane, a binding reaction between the reagent and the analyte takes place. The extent of this binding or simply the presence of the analyte, depen-ling on whether the assay is a 30 competition or a sandwich format, is measured at a detection site, where specific binding with the immobilized reagent occurs. Unbound material continues to migrate downstream towards the terminal end of the main membrane and is partially captured at the control site. No unbound labeled reagent rem~in~ in the detection or the control sites.
21673~
On the main membrane there is a detection site where specific bin-ling reagent (generally unlabeled) is immobilized (that is, the immobilized specific bintling reagent cannot be washed away by a developing liquid).
Downstream of the detection site there is a control site, where another 5 binding reagent is immobilized. When assembled, the top membrane is in contact with the upper surface of the main membrane upstream of the detection site (see FIG lD).
Optionally, a sample pad can be used to absorb a liquid sample and release the liquid into the beginning end of the main membrane. The sample pad is typically fashioned from a blotting material, and is in contact with the main membrane. The sample pad may optionally contain additional reagents.
Optionally, a "sink" pad, fashioned from a blotting material, can be used at the terminal end of the main membrane to absorb excess reagent solution and foster c~pill~qry flow in the main membrane for a longer period of time.
The membranes and the pads are preferably disposed in a holder. The use of a sample pad and a sink pad are described in U.S. Patent Nos.
4,966,302 and 5,238,652, the contents of which are herein incorporated by ao reference. A s_illed artisan having read the present specification would be able to use such pads in connection with the present invention.
Examples of suitable top and main membranes include bibulous or fibrous material capable of capillary action, such as thin layer chromatography materials, paper or cellulose chromatography substrates, 25 porous synthetic plastics, etc. Preferred absorbent materials have good wicking ability, a smooth surface which insures good contact between the "main" and "top" membranes, reversible binding of the labeled compound to the membrane to promote quantitative mobilization, ability to transport a labeled reagent by capillary action, availability of wicking characteristics 30 within suitable range, reproducible and convenient reagent application and handling.
Preferred membranes include nitrocellulose and nylon. Moreover, memb-ranes precast on plastic are preferred because of handling convenience. Nitrocellulose is desirable because it (i) is able to bind proteins35 by adsorption without requiring complicated covalent linking, (ii) has ~1673~
excellent wicking characteristics, and (iii) is available in a convenient range of pore sizes. Backed nitrocellulose (for egample, precast on a plastic material), is most preferred. Procedures for adsorption of specific proteins on nitrocellulose to form detection and control sites, and blocking of 6 unoccupied binding sites on the nitrocellulose with neutral blocking reagent are well known in the art (see for example, Harvey, M.A., Optimization of Nitrocellulose Membrane-Based Immunoassays, Schleicher & Schuell. No.
557, pp. 18-23, 1991).
Migration rates vary with membrane properties, for example, pore size.
Selection of flow rate, appropriate membrane type, and pore size is within the knowledge of the skilled artisan, and can be determined with minim~l experimentation.
Because of the fluid dynamics within the top membrane, reagent (typically labeled) tends to concentrate at the forward edge of the top 6 membrane and seep slowly into the main membrane where it mixes with the first flow. The extent of dilution has been postulated to be controlled by flow dynamics in the present invention rather than by the rate of reagent mobili~tion, as in known formats. Thus, the subject invention provides the advantage of relatively constant concentration of the top membrane reagent 20 within the reunited flow which occurs downstream in the main membrane.
This constant concentration of reagent is maintained as long as the reagent supply in the top membrane lasts.
The rate of reagent dilution from the top membrane can be controlled by choosing an appropriate difference in wicking rates between the main 26 membrane and the top membrane. "Wicking rate" refers to the speed of liquid movement within the membrane (distance/time). The top membrane can be made from the same material or other suitable porous carrier material. However, for convenience, the top and the main membranes are generally made from the same material. Such a choice of appropriate 30 membrane materials is readily made by the skilled artisan having read the present specification. For instance, when a higher rate of dilution is required, reagent can be applied via a membrane having slower wicking properties, for example, by using a membrane having a smaller pore size.
The wicking rate for the main membrane is preferably higher than or 35 equal to the wicking rate of the top membrane. As a result, reagent from the ~1~7362 top membrane permeates into the main membrane behind the liquid front in the main membrane, thus allowing the first flow to prewet the main membrane. Prewetting advantageously (i) facilitates uniform migration of the reagent from the top membrane, (ii) elimin~tes or at least significantly reduces negative effect of hydrophobicity due to unlabeled bin(l;ng reagents at the detection site, and (iii) facilitates binding at the detection site.
A labeled binding reagent is normally applied to a membrane which has previously been blocked with a blocking compound in order to avoid non-0 specific binding of a labeled reagent to the membrane surface.
The membrane can be cut and the test strips assembled in any suitablemanner. Alternatively, the membrane may be pre-formed to certain tlimen~ional specifications. For instance, it can be convenient to assemble large segments first by securing the top membrane on the surface of the ~5 main membrane, which is then cut into strips. The top membrane preferably is the same width as the main membrane, or is more narrow.
The length of each membrane is determined empirically, but relatively short membranes with the dimensions just sufficient to accommodate the required amount of a bin-ling reagent are preferred. Exact distance between ~o the membrane and the detection site is determined by balancing the time required for proper mi~ing of the reagents and completion of a bin~inE
reaction, with the deterioration of uniform migration if the distance is too long. Such special parameters can be determined through minim~l experimentation. Presently, a distance in the range from 0.5 cm to 6 cm is 2~ preferred. Position of the top membrane on the main membrane is upstream of the detection site, but downstre~m of the sample application site.
Lamination of the main and top membranes further prevents occasional membrane flooding due to excess sample traveling outside of the 30 membranes. If a flood wave of sample reaches the location where reagent is imbedded, it may completely distort the test result. This problem is particularly acute in the applications where the sample migrates downwards.
(~ontact between the top and main membranes can be achieved in a 35 number of ways. For instance, the main and the top membranes can be ~1~7~
pressed against each other by housing elements, or may be l~min~ted one to another, or both. T~min~tion is preferred because a reliable "tight" contact is achieved. Moreover, the l~min~te acts as a dam to prevent flooding. A
preferred way to m~imi~e contact between the membranes, involves 5 l~min~ting the top membrane over the main membrane in juxtaposition using a polyester film, such as the mylar tape described in the following example.
Currently it is preferred for reagent from the top membrane not to cross the interface between the membranes to any appreciable extent, but rather to 0 be transported completely inside the top membrane towards the forward edge.
Figures lA through lD, depict a specific device which utilizes chromatographic principles to perform specific binding assays. Three porous carrier membranes testing three different analytes are shown in a plastic holder (102). Such a holder may form a portion of an assaying device of the type disclosed by European Patent Application with publication No. EP-A-0668745, the contents of which are herein incorporated by reference.
Typically, plastic holder (102) will retain three to five porous carrier membranes. FIG. lA shows three porous carrier membranes, whereas ao FIG. lC shows windows for five porous carrier membranes.
Main membrane (101) contains detection site (103) and control site (104). Labeled specific binding reagent (105) is embedded in top membrane (106) which contacts the upper surface of main membrane (101). Top membrane (106) is tightly attached to main membrane (101) with a polyester 25 film with adhesive backing, e.g. with adhesive mylar tape (107). Contacting, and preferably slightly overlapping, be~inning end (108) of each main membrane (101) is sample pad (109). Sample contacts sample pad (109) through several small holes in the back side of the pad (not shown). A soft rubber seal (110) sits on the top of sample pad (109). The degree of softness 30 needed is readily determined by the skilled artisan. Seal (110) is somewhat dimensionally larger than s~mple pad (109), so that it covers sample pad (109) and seals it along its borders when squeezed.
Sealing is required to prevent leakage of the sample when the chromatographic membranes are installed vertically (sample migrates in a 35 downwards direction). Of course, a seal (110) can also be used when the ~1~7~
apparatus is used in other than a vertical position. Absorbent pad (111) at the terminal end (112) of the chromatographic membranes is common to all three membranes. Each detection site can be observed through a cross-shaped result window (113) and the corresponding control site through a 5 circular control window (114) of the cover panel (115). The plastic of the cover panel is typically not transparent. The cross-shaped result window labeled with COC is for an assay for the detection of benzoylecgonine in urine. The cross-shaped result window labeled with THC, which stands for Tetrahydroc~nn~binoids, is for an assay for the detection of c~nn~hinoids in ID urine. The cross-shaped result window labeled with MOR is for an assay for the detection of opiates in urine. The appearance of a blue bar in each of the round windows 114 labeled TEST COMPLETE indicates that the corresponding test has run to completion and that the results may be interpreted. These windows 114 expose an area of the membrane strip that is 5 coated with anti-bovine serum albumin antibodies. Late~ microparticles are overcoated with bovine serum albllmin so that when they migrate past this area of the membrane the antibody binds to the bovine serum albumin and captures the microparticle.
The present invention is particularly useful in a competition assay 20 format. In one version of this format, the labeled reagent in the top membrane is either the analyte itself or an analog capable of the same type of specific binding. The labeled reagent is mobilized and diluted by a sample, and migrates with the sample towards the detection site, where unlabeled reagent capable of binding the analyte or its structural analog is 25 immobilized. If analyte is present in a sample, it will compete with the labeled reagent for a limited number of binding sites in the detection zone, and the relative concentration of the analyte can be determined from the extent of reduction of hin~ling of the labeled reagent.
In another version, competition is time resolved. In this case, the 30 labeled reagent is a binding partner of the analyte or of its structural analog.
The labeled reagent is mobilized and diluted by a sample, and then migrates with the sample towards the detection site, where the unlabeled analyte or its analog is immobilized. If analyte is present in the s~mple, then during the course of migration it will bind to the labeled reagent. Rem~ining 35 unsaturated binding sites of the labeled reagent can bind to the immobilized reagent in the detection site. Once again, concentration of the analyte can be determined from the extent of reduction of binding of the labeled reagent.
~1~136~
For both versions of the competition format, the ratio of concentrations of bin~ling components in migrating liquid should not fluctuate significantly over the rlimen~ions of the labeled reagent moving zone. Also, uniformity should not decay over the terrn of migration to the detection site. Deviation in5 flow uniformity allows competition to fluctuate, and leads to poorly reproducible results. The present invention minimi~es non-uniformity, and improves sensitivity by m~king the labeled reagent more dilute (as described below).
Discrimination between zero analyte level and cut-off analyte level can lD be improved by increasing the total amount of labeled reagent and increasing the volume in which it is presented. As a result, analytical signal at zero drug level becomes stronger, while the signal at cut-off level iskept lln~h~nged, the steeper calibration curve allows better discrimin~tion.
The present invention is also useful in a sandwich format. In this format, both the labeled reagent and the unlabeled immobilized reagent are the binding partners of the analyte (though they typically should bind to different epitopes of the analyte). Preferably both the labeled and immobilized unlabeled reagents are present in excess of the analyte. If analyte is present ao in the sample, then during the course of migration it will fully bind to the labeled reagent. In the detection site, analyte, which is already bound to the labeled reagent, will bind to the immobilized reagent, forming the sandwich.
The analyte concentration is directly proportional to the binding at the detection site.
The following e~mple of a morphine assay is provided to illustrate the invention. It must be pointed out, however, that the present invention is not limited to any particular substance.
Morphine derivative - N-[3-[(7,8-Didehydro-4,5-epoxy-6-hydro-17-methyl-30 morphinan-3-yl)oxy]propoxy]-4-isothiocyanatobenzamide- was prepared as described in European Application with publication No. EP-A-0386644.
Conjugation of this morphine derivative to bovine serum albumin (BSA) was performed as follows: To a solution of BSA (approximately 57 mg/mL) 6~
in 50 mM potassium phosphate, pH 8, (438 mL) (cooled in an ice bath), dimethylsulfoxide (DMSO) was added dropwise (188 mL). After warming to 25 C, a 5 mg/mL solution of the above mentioned derivative in DMSO (190 ml) was added dropwise. The reaction mixture was stirred at room 5 temperature for 16 hours and then transferred to dialysis tubing and dialyzed first against 15 volumes of 20% DMSO - potassium phosphate buffer (50 mM, pH 8), second against 10% DMSO - potassium phosphate buffer, and third for four times more against potassium phosphate buffer.
Colored uniform carboxylate-modified styrene microparticles, e.g. blue 0 latex from Seradyn (0.3 micron particles), was first washed three times at 1% solids by centrifuging in 20 mM, pH 6.1 MES (2-[N-morpholino]ethanesulfonic acid). The washed latex was then adjusted to 5%
solids in MES and (i) sensitized with 2 mg/mL anti-morphine monoclonal antibody for 16 hours at room temperature, (ii) blocked with BSA solution in 5 MES for 1 hour at room temperature, then (iii) washed for three times at 1%
solids in MES by centrifugation, and (*) adjusted again to 5% solids. Before use, equal volumes of this lateg and 35% w/v sucrose in MES were mixed.
Large pore size nitrocelullose cast directly on polyester film, e.g. Mylar backed large pore size nitrocellulose (10-20 micron) from Millipore, was cut ~o into pieces of 10 cm in length and 5 cm in width. Solution of morphine-BSA
conjugate (about 5 mg/mL) and anti-BSA monoclonal Ab (about 2 mg/mL), both in 50 mM potassil7m phosphate buffer pH 7.5, were dispensed using a positive displacement liquid dispensing system, e.g. IVEK Corp. Digispense 2000TM system, at the rate 1 ~lVcm onto nitrocellulose at a distance 25 respectively 2 cm and 1 cm from the 10 cm side. Nitrocellulose segments were allowed to dry for about 30 min. at 37C and then were blocked with 1%
w/v polyvinyl alcohol (PVA, m.w. 13,000-23,000) solution in 20 mM Tris, pH
8, for 30 min. at room temperature. The segments were then rinsed in water and dried.
Sample pads were prepared by cutting a cellulose filter paper, e.g.
BioRad gel blotter, into 0.5 cm2 pieces. The same cellulose filter paper was used for the sink pads.
The same nitrocellulose as described above in this example was used as a separate membrane for latex (top membrane). For this purpose the 35 nitrocellulose, which was previously blocked in the same m~nner as the ~16~6~
main membrane, was cut into 5 mm wide strips and latex was applied using the IVEK dispen~ing system. After drying for 30 min. at 37C, this membrane was placed, nitrocellulose surface down, onto the main membrane and l~min~ted to the main membrane with a polyester film with 5 adhesive b~cking, e.g. with Adhesive Research Inc. adhesive mylar. After this, the segment was cut into 5 mm wide strips, sample pad and sink pad placed respectively at the beeinning and terminal ends of the strips, and the calibration curve obtained using solutions cont~ining predetermined amounts of the drug (morphine sulfate).
0 The optimal calibration curve (1.1 ~lVcm of latex) is shown in FIG. 2.
This curve, and the following curves shown in Figures 3 to 8, were obtained by determining the colorimetric density of the result bands using a tristimulus reflective color analyzer, e.g. Minolta CR-241 Chroma Meter.
In the graphs shown in Figures 2 to 8, the vertical axis indicates values measured with Minolta CR-241 Chroma Meter multiplied by 1000. This is indicated by the label "Minolta reading x 1000". This Minolta re~tlings are ta_en from the colorimetric density, Dx, derived from the X, Y, Z tristimulus values as determined by the CIE (Commission Internationale de l'Eclairage). The tristimulus values are derived from the Yxy color system ao established by the CIE in 1931, wherein Y is the lightness factor and x and yare the coordinates of the chromaticity diagram. The tristimulus value X is related to the tristimulus value Y by the equation X= Y(~/y). Dx, the colorimetric density of X, is derived from the equation Dx= - log1o (Xm/Xo) where Xm= the measured X tristimulus value of the result band and Xo =
25 the measured X tristimulus value of the light source.
For each strip colorimetric density (Dx) in the red part of spectrum was measured at five points on the conjugate (or result) band, each point 1 mm apart from the neighboring one. Background colorimetric density level was measured off the result band. Average re~-1ing, st~n-1~rd deviation and 30 %CV (percent coeffficient of variation) were calculated.
For comparison, latex was applied directly to the main membrane.
Optimal calibration curves (0.5 ~Vcm of latex) is shown in FIG. 3. When latex volume larger than 0.5 ~Vcm was deposited onto the membrane, inhibition at cut-off concentration (300 ng/ml) was poor.
~1673~
Uniformity of the result band and control band can be characterized by color intensity variation for the five re~-ling points. Table 1 presents %CV in control and result band intensities.
Table 1 Variation (%CV) in result and control band inten~ity MoIl7hine standard concentration Fig. No. 0 ng/mT. 75 ng/ml 150 ng/mL Control anti-BSA
2 8.0 9.3 15.6 5.3 3 24.1 17.1 151.9 22.7 ~lru?le 2 This example of a tetrahydroc~nn~hinoid assay further illustrates the invention.
Nitrocellulose membranes as described for this invention in Example 1 were prepared using: a tetrahydroc~qnn~hinoid-BSA conjugate prepared simil~rly to the morphine-BSA conjugate, but at a 20:1 drug derivative to BSA ratio; J3-cyclodextrin incorporated into the s~mple pad; and blue latex sensitized with anti-tetrahydroc~nn~binoid monoclonal antibodies.
L5 Analysis of the colored results bands were performed as in Example 1. An optimal calibration curve of 3.0 ~Vcm latex is shown in FIG. 4.
FIG. 5 and FIG. 6 show optimal THC curves when the latex is applied directly to the main membrane (1 ~Vcm) by the IVEK system and a compressed air liquid dispensing system or airbrush, e.g. a Paasche ao Company airbrush, respectively.
Performance of the format, where late~ is deposited over a sublayer of sucrose glaze (35% to 66% w/v sucrose in water) was also evaluated. An optimal curve with 60% sucrose sublayer and 2.0 ~Vcm late~ is presented FIG. 7. A different latex formulation, where late~ solution was prepared in 25 1% methylcellulose, e.g. in 1% Methocel K4MTM methylcellulose (Dow 21673~
Chemical Company) and 0.6% w/v PVA and applied directly on top of the sucrose sublayer, as was suggested in EP-A-0 291 194, was also evaluated (FIG. 8). More than half of the latex does not even begin to migrate in this case. The sucrose sublayer also slows migration of late~ strongly, and 5 migration is not uniform.
Uniformity of the result band and control band can be characterized by color intensity variation for the five re~-ling points. Table 2 presents %CV in control and result band intensities.
Table 2 Variation (%CV) in result and control band intensity THC standard concentration Fig. No. 0 ng/mL 12.5 ng/ml 25 ng/mL Control anti-BSA
4 15.5 7.9 12.5 5.3 21.4 33.1 37.2 22.7 6 40.8 21.5 52.7 44.3 7 31.8 31.2 54.8 66.0 8 21.6 86.6 22.9 22.6 As is clear from the results of the above two examples, the present apparatus offers superior results when compared with the systems of the prior art.
Upon reading the present specification, numerous alternative embodiments will become obvious to the skilled artisan. These variations are to be considered within the scope and spirit of the invention which is only to be limited by the claims which follow and their equivalents.
Sample pads were prepared by cutting a cellulose filter paper, e.g.
BioRad gel blotter, into 0.5 cm2 pieces. The same cellulose filter paper was used for the sink pads.
The same nitrocellulose as described above in this example was used as a separate membrane for latex (top membrane). For this purpose the 35 nitrocellulose, which was previously blocked in the same m~nner as the ~16~6~
main membrane, was cut into 5 mm wide strips and latex was applied using the IVEK dispen~ing system. After drying for 30 min. at 37C, this membrane was placed, nitrocellulose surface down, onto the main membrane and l~min~ted to the main membrane with a polyester film with 5 adhesive b~cking, e.g. with Adhesive Research Inc. adhesive mylar. After this, the segment was cut into 5 mm wide strips, sample pad and sink pad placed respectively at the beeinning and terminal ends of the strips, and the calibration curve obtained using solutions cont~ining predetermined amounts of the drug (morphine sulfate).
0 The optimal calibration curve (1.1 ~lVcm of latex) is shown in FIG. 2.
This curve, and the following curves shown in Figures 3 to 8, were obtained by determining the colorimetric density of the result bands using a tristimulus reflective color analyzer, e.g. Minolta CR-241 Chroma Meter.
In the graphs shown in Figures 2 to 8, the vertical axis indicates values measured with Minolta CR-241 Chroma Meter multiplied by 1000. This is indicated by the label "Minolta reading x 1000". This Minolta re~tlings are ta_en from the colorimetric density, Dx, derived from the X, Y, Z tristimulus values as determined by the CIE (Commission Internationale de l'Eclairage). The tristimulus values are derived from the Yxy color system ao established by the CIE in 1931, wherein Y is the lightness factor and x and yare the coordinates of the chromaticity diagram. The tristimulus value X is related to the tristimulus value Y by the equation X= Y(~/y). Dx, the colorimetric density of X, is derived from the equation Dx= - log1o (Xm/Xo) where Xm= the measured X tristimulus value of the result band and Xo =
25 the measured X tristimulus value of the light source.
For each strip colorimetric density (Dx) in the red part of spectrum was measured at five points on the conjugate (or result) band, each point 1 mm apart from the neighboring one. Background colorimetric density level was measured off the result band. Average re~-1ing, st~n-1~rd deviation and 30 %CV (percent coeffficient of variation) were calculated.
For comparison, latex was applied directly to the main membrane.
Optimal calibration curves (0.5 ~Vcm of latex) is shown in FIG. 3. When latex volume larger than 0.5 ~Vcm was deposited onto the membrane, inhibition at cut-off concentration (300 ng/ml) was poor.
~1673~
Uniformity of the result band and control band can be characterized by color intensity variation for the five re~-ling points. Table 1 presents %CV in control and result band intensities.
Table 1 Variation (%CV) in result and control band inten~ity MoIl7hine standard concentration Fig. No. 0 ng/mT. 75 ng/ml 150 ng/mL Control anti-BSA
2 8.0 9.3 15.6 5.3 3 24.1 17.1 151.9 22.7 ~lru?le 2 This example of a tetrahydroc~nn~hinoid assay further illustrates the invention.
Nitrocellulose membranes as described for this invention in Example 1 were prepared using: a tetrahydroc~qnn~hinoid-BSA conjugate prepared simil~rly to the morphine-BSA conjugate, but at a 20:1 drug derivative to BSA ratio; J3-cyclodextrin incorporated into the s~mple pad; and blue latex sensitized with anti-tetrahydroc~nn~binoid monoclonal antibodies.
L5 Analysis of the colored results bands were performed as in Example 1. An optimal calibration curve of 3.0 ~Vcm latex is shown in FIG. 4.
FIG. 5 and FIG. 6 show optimal THC curves when the latex is applied directly to the main membrane (1 ~Vcm) by the IVEK system and a compressed air liquid dispensing system or airbrush, e.g. a Paasche ao Company airbrush, respectively.
Performance of the format, where late~ is deposited over a sublayer of sucrose glaze (35% to 66% w/v sucrose in water) was also evaluated. An optimal curve with 60% sucrose sublayer and 2.0 ~Vcm late~ is presented FIG. 7. A different latex formulation, where late~ solution was prepared in 25 1% methylcellulose, e.g. in 1% Methocel K4MTM methylcellulose (Dow 21673~
Chemical Company) and 0.6% w/v PVA and applied directly on top of the sucrose sublayer, as was suggested in EP-A-0 291 194, was also evaluated (FIG. 8). More than half of the latex does not even begin to migrate in this case. The sucrose sublayer also slows migration of late~ strongly, and 5 migration is not uniform.
Uniformity of the result band and control band can be characterized by color intensity variation for the five re~-ling points. Table 2 presents %CV in control and result band intensities.
Table 2 Variation (%CV) in result and control band intensity THC standard concentration Fig. No. 0 ng/mL 12.5 ng/ml 25 ng/mL Control anti-BSA
4 15.5 7.9 12.5 5.3 21.4 33.1 37.2 22.7 6 40.8 21.5 52.7 44.3 7 31.8 31.2 54.8 66.0 8 21.6 86.6 22.9 22.6 As is clear from the results of the above two examples, the present apparatus offers superior results when compared with the systems of the prior art.
Upon reading the present specification, numerous alternative embodiments will become obvious to the skilled artisan. These variations are to be considered within the scope and spirit of the invention which is only to be limited by the claims which follow and their equivalents.
Claims (23)
1. An apparatus for conducting a binding assay, which comprises:
(a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
(a) a first absorbent material having a first reagent immobilized thereon at a first predetermined location; and (b) a second absorbent material in contact with the first absorbent material and having a second reagent releasably immobilized thereon at a second predetermined location, the first absorbent material and the second absorbent material being positioned in juxtaposition to each other so that a flow of liquid through the first absorbent material causes the second reagent to be released from the second absorbent material and flow through the first absorbent material.
2. The apparatus of claim 1, wherein the first absorbent material and the second absorbent material are composed of the same material.
3. The apparatus of claim 1, wherein the first absorbent material is selected from the group consisting of bibulous membranes and porous membranes.
4. The apparatus of claim 1, wherein the second absorbent material is selected from the group consisting of bibulous membranes and porous membranes.
5. The apparatus of claim 3, wherein the absorbent material is nitrocellulose.
6. The apparatus of claim 4, wherein the absorbent material is nitrocellulose.
7. An apparatus of claim 1, wherein the first absorbent material and the second absorbent material are held in contact with each other by a holder.
8. An apparatus of claim 1, wherein the first absorbent material and the second absorbent material are held in contact with each other by a band of material.
9. An apparatus of claim 8, wherein the material is a polyester film.
10. An apparatus of claim 1, wherein the second reagent is labeled.
11. An apparatus of claim 1, wherein the first absorbent material has a plurality of reagents immobilized thereon.
12. An apparatus of claim 1, wherein the second absorbent material has a plurality of reagents immobilized thereon.
13. An apparatus of claim 10, wherein the label is a colored latex.
14. An apparatus of claim 1, wherein the first reagent and the second reagent have an affinity to bind with each other.
15. An apparatus of claim 1, wherein the wicking rate of the first absorbent material is the same or higher than the wicking rate of the second absorbent material.
16. An apparatus of claim 1, wherein the wicking rate of the first absorbent material is lower than the wicking rate of the second absorbent material.
17. An apparatus of claim 1, wherein the first reagent is irreversibly immobilized on the first absorbent material.
18. An apparatus of claim 1, wherein the first absorbent material and the second absorbent material each have planar surfaces.
19. An apparatus of claim 18, wherein the planar surface of the first absorbent material is juxtaposed to the planar surface of the second absorbent material.
20. An apparatus of claim 1, wherein the first reagent and the second reagent each have an affinity to bind with the same substance.
21. A method for conducting a binding assay, which comprises:
(a) introducing a liquid sample into a first absorbent material to generate a first flow of liquid within the first absorbent material;
(b) introducing the liquid from the first absorbent material into a second absorbent material to generate a second flow of liquid within the second absorbent material while maintaining the first flow of liquid within the first absorbent material;
(c) introducing a second reagent into the second flow of liquid within the second absorbent material, the second flow, after the introduction of the second reagent, being in a direction generally parallel to the first flow of liquid within the first absorbent material; and (d) introducing the second flow of liquid and the second reagent from the second absorbent material into the first absorbent material to unite with the first flow of liquid within the first absorbent material.
(a) introducing a liquid sample into a first absorbent material to generate a first flow of liquid within the first absorbent material;
(b) introducing the liquid from the first absorbent material into a second absorbent material to generate a second flow of liquid within the second absorbent material while maintaining the first flow of liquid within the first absorbent material;
(c) introducing a second reagent into the second flow of liquid within the second absorbent material, the second flow, after the introduction of the second reagent, being in a direction generally parallel to the first flow of liquid within the first absorbent material; and (d) introducing the second flow of liquid and the second reagent from the second absorbent material into the first absorbent material to unite with the first flow of liquid within the first absorbent material.
22. A method of claim 21, wherein the first flow of liquid within the first absorbent material flows at the same or greater velocity than the second flow of liquid within the second absorbent material.
23. A method of claim 21, wherein the first flow of liquid within the first absorbent material flows at a lesser velocity than the second flow of liquid within the second absorbent material.
***
***
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38530095A | 1995-02-10 | 1995-02-10 | |
| US08/385,300 | 1995-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2167362A1 true CA2167362A1 (en) | 1996-08-11 |
Family
ID=23520835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002167362A Abandoned CA2167362A1 (en) | 1995-02-10 | 1996-01-16 | Apparatus and method for conducting a binding assay on an absorbent carrier material |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5770458A (en) |
| EP (1) | EP0726462B1 (en) |
| JP (1) | JP4007624B2 (en) |
| AT (1) | ATE215699T1 (en) |
| CA (1) | CA2167362A1 (en) |
| DE (1) | DE69620281T2 (en) |
| ES (1) | ES2173216T3 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342183B1 (en) | 1997-02-14 | 2002-01-29 | Escreen | System for collecting and locally analyzing a fluid specimen |
| US6514461B1 (en) * | 1997-02-14 | 2003-02-04 | Escreen, Inc. | System for automatically testing a fluid specimen |
| KR100292182B1 (en) * | 1997-09-18 | 2001-11-26 | 모리시타 요이찌 | Immunochromatography Devices |
| US6168758B1 (en) * | 1997-11-19 | 2001-01-02 | Starplex Scientific | Liquid sample assay device |
| US6306642B1 (en) | 1997-11-24 | 2001-10-23 | Quidel Corporation | Enzyme substrate delivery and product registration in one step enzyme immunoassays |
| EP1496348B1 (en) * | 1998-03-31 | 2012-08-15 | Evotec AG | Multi-well container |
| US8623291B2 (en) | 1998-07-14 | 2014-01-07 | Jin Po Lee | Multiple analyte assay device |
| AU8662598A (en) * | 1998-07-22 | 2000-02-14 | Syntron Bioresearch, Inc. | Multiple analyte assay device |
| US8202487B2 (en) * | 1998-07-22 | 2012-06-19 | Jin Po Lee | Multiple analyte assay devices |
| US6379620B1 (en) * | 1998-11-16 | 2002-04-30 | Barry M. Tydings | Assaying device and method for in field urinalysis |
| US6514769B2 (en) * | 1999-07-29 | 2003-02-04 | Jin Po Lee | Multiple analyte assay device with sample integrity monitoring system |
| US6136549A (en) * | 1999-10-15 | 2000-10-24 | Feistel; Christopher C. | systems and methods for performing magnetic chromatography assays |
| US6534324B1 (en) * | 2000-05-12 | 2003-03-18 | Mizuho Usa, Inc. | Rapid assay strip and method of rapid competitive assay |
| DE10032290C2 (en) * | 2000-07-03 | 2002-05-08 | Roche Diagnostics Gmbh | Control liquid containing adsorbent |
| US6492127B2 (en) * | 2001-01-23 | 2002-12-10 | Varian, Inc. | Lateral flow testing device with on-board chemical reactant |
| KR20030008748A (en) * | 2001-07-20 | 2003-01-29 | 한국과학기술연구원 | A Immunostrip Paper for the Simultaneous Detection of Philopon and Cannabis |
| US7049150B2 (en) * | 2001-12-28 | 2006-05-23 | Varian, Inc. | Binding assay device with non-absorbent carrier material |
| US7029918B2 (en) * | 2002-01-25 | 2006-04-18 | Roche Diagnostics Operations, Inc. | Water-soluble derivatives of lipophilic drugs |
| US6805838B2 (en) * | 2002-03-04 | 2004-10-19 | Barry M. Tydings | Assaying device and method for in field urinalysis |
| US7695752B2 (en) * | 2003-01-24 | 2010-04-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
| CA2513646C (en) * | 2003-01-24 | 2013-09-17 | Michael R. Emmert-Buck | Target activated microtransfer |
| US20040184965A1 (en) * | 2003-03-18 | 2004-09-23 | Smith Jack V. | Testing cup |
| EP1613578A2 (en) * | 2003-04-10 | 2006-01-11 | Mallinckrodt Inc. | Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
| US7393697B2 (en) * | 2003-06-06 | 2008-07-01 | Advantage Diagnostics Corporation | Diagnostic test for analytes in a sample |
| DE10330981B4 (en) * | 2003-07-09 | 2010-04-01 | Medion Diagnostics Ag | Apparatus and method for simultaneously performing blood grouping, serum cross-checking and antibody-screening |
| DE10330982A1 (en) * | 2003-07-09 | 2005-02-17 | Prisma Diagnostika Gmbh | Apparatus and method for the simultaneous determination of blood group antigens |
| US20060216833A1 (en) * | 2004-06-24 | 2006-09-28 | The Regents Of The University Of California | Spot test kit for explosives detection |
| EP1657551A1 (en) * | 2004-11-11 | 2006-05-17 | EnviteC-Wismar GmbH | Method and kit for detecting cannabinoids |
| US20060199276A1 (en) * | 2005-03-07 | 2006-09-07 | Bernhard Armani | Device for multiple rapid detection and testing of diseases, disorders and immunity in human, animals and the environment |
| US20070020699A1 (en) * | 2005-07-19 | 2007-01-25 | Idexx Laboratories, Inc. | Lateral flow assay and device using magnetic particles |
| CN100478671C (en) * | 2005-10-25 | 2009-04-15 | 艾康生物技术(杭州)有限公司 | Detector and method for liquid sampler |
| JP2007187650A (en) * | 2005-12-16 | 2007-07-26 | Horiba Ltd | Fipronyl measuring kit using immunoassay |
| US7749772B1 (en) | 2006-06-29 | 2010-07-06 | Varian, Inc. | Antibody and immunoassays for determining the presence of Δ9-Tetrahydrocannabinol |
| US20080019867A1 (en) * | 2006-07-22 | 2008-01-24 | Johnson Paul K | Urinalysis screening device |
| US20080153110A1 (en) * | 2006-10-25 | 2008-06-26 | Tim Scherkenback | Combination Rapid Detection Cartridges For Biological and Environmental Agents, Methods of Production and Uses Thereof |
| WO2008141351A1 (en) * | 2007-05-21 | 2008-11-27 | Erber Aktiengesellschaft | Method for quantitatively determining analytes using a test element and test system and use thereof |
| CN101603967B (en) * | 2008-06-10 | 2015-02-18 | 英科新创(厦门)科技有限公司 | Method for fast testing human ABO/Rh/MN blood type and kit |
| US9332967B2 (en) * | 2009-04-16 | 2016-05-10 | Ameditech, Inc. | Invertable assaying device with fluid level adjusting cover |
| JP5852329B2 (en) * | 2011-05-31 | 2016-02-03 | 積水メディカル株式会社 | Method for immunological measurement of HbA1c |
| CN103792365A (en) * | 2012-11-05 | 2014-05-14 | 江苏维赛科技生物发展有限公司 | Preparation and application method of fusarium moniliforme colloidal gold test strip |
| WO2014081460A1 (en) * | 2012-11-20 | 2014-05-30 | Kisner Mark | Chemical sequencing and control to expand and enhance detection capabilities utilizing a colorimetric test |
| JP6226624B2 (en) * | 2013-08-08 | 2017-11-08 | 田中貴金属工業株式会社 | Hemolytic streptococcal diagnostic immunochromatographic reagent, kit and detection method |
| JP6026595B2 (en) * | 2015-06-08 | 2016-11-16 | 積水メディカル株式会社 | Method for immunological measurement of HbA1c |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857931A (en) * | 1971-02-01 | 1974-12-31 | Hoffmann La Roche | Latex polymer reagents for diagnostic tests |
| US4094647A (en) * | 1976-07-02 | 1978-06-13 | Thyroid Diagnostics, Inc. | Test device |
| US4121975A (en) * | 1976-08-20 | 1978-10-24 | Syva Company | Pretreatment of samples for polyiodothyronine assays |
| US4361537A (en) * | 1979-01-12 | 1982-11-30 | Thyroid Diagnostics, Inc. | Test device and method for its use |
| US4235601A (en) * | 1979-01-12 | 1980-11-25 | Thyroid Diagnostics, Inc. | Test device and method for its use |
| US4938927A (en) * | 1982-01-08 | 1990-07-03 | Environmental Diagnostics, Inc. | Rotary fluid manipulator |
| HU194858B (en) * | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
| DE3445816C1 (en) * | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flat diagnostic agent |
| GB8526741D0 (en) * | 1985-10-30 | 1985-12-04 | Boots Celltech Diagnostics | Binding assay device |
| CA1291031C (en) * | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
| DE3643516A1 (en) * | 1986-12-19 | 1988-06-30 | Boehringer Mannheim Gmbh | TEST CARRIER FOR THE ANALYTICAL DETERMINATION OF INGREDIENTS OF BODY LIQUIDS |
| US4798804A (en) * | 1987-02-05 | 1989-01-17 | Syntex (U.S.A.) Inc. | Serum pretreatment in digoxin immunoassay |
| DE3856542T2 (en) * | 1987-04-27 | 2003-10-30 | Inverness Medical Switzerland | Test device for carrying out specific binding tests |
| US4956302A (en) * | 1987-09-11 | 1990-09-11 | Abbott Laboratories | Lateral flow chromatographic binding assay device |
| US5275785A (en) * | 1987-10-30 | 1994-01-04 | Unilever Patent Holdings B.V. | Test device for detecting an analyte in a liquid sample |
| DE3826057A1 (en) * | 1988-07-30 | 1990-02-01 | Boehringer Mannheim Gmbh | TEST TESTER FOR THE ANALYTICAL DETERMINATION OF AN INGREDIENT OF A LIQUID SAMPLE |
| DE3842702A1 (en) * | 1988-12-19 | 1990-06-21 | Boehringer Mannheim Gmbh | TEST CARRIER FOR ANALYTICAL EXAMINATION OF A SAMPLING LIQUID WITH THE AID OF A SPECIFIC BINDING REACTION OF TWO BIOAFFIN BINDING PARTNERS AND A CORRESPONDING TEST PROCEDURE |
| DK0386644T3 (en) * | 1989-03-10 | 1997-10-13 | Hoffmann La Roche | Reagents for the determination of drugs |
| GB8920135D0 (en) * | 1989-09-06 | 1989-10-18 | Erba Carlo Spa | Use of dehydrated cyclodextrins for improving drug dissolution |
| US5238652A (en) * | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
| GB9014903D0 (en) * | 1990-07-05 | 1990-08-22 | Unilever Plc | Assays |
| US5411893A (en) * | 1993-03-15 | 1995-05-02 | Difco Laboratories | Dry slide for diagnostic tests |
| US5403551A (en) * | 1993-09-16 | 1995-04-04 | Roche Diagnostic Systems, Inc. | Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen |
-
1996
- 1996-01-16 CA CA002167362A patent/CA2167362A1/en not_active Abandoned
- 1996-01-31 AT AT96101322T patent/ATE215699T1/en not_active IP Right Cessation
- 1996-01-31 EP EP96101322A patent/EP0726462B1/en not_active Expired - Lifetime
- 1996-01-31 ES ES96101322T patent/ES2173216T3/en not_active Expired - Lifetime
- 1996-01-31 DE DE69620281T patent/DE69620281T2/en not_active Expired - Lifetime
- 1996-02-08 JP JP02275896A patent/JP4007624B2/en not_active Expired - Lifetime
-
1997
- 1997-06-17 US US08/877,189 patent/US5770458A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69620281D1 (en) | 2002-05-08 |
| JP4007624B2 (en) | 2007-11-14 |
| DE69620281T2 (en) | 2002-10-31 |
| EP0726462B1 (en) | 2002-04-03 |
| ATE215699T1 (en) | 2002-04-15 |
| JPH08248030A (en) | 1996-09-27 |
| EP0726462A1 (en) | 1996-08-14 |
| US5770458A (en) | 1998-06-23 |
| ES2173216T3 (en) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0726462B1 (en) | Apparatus and method for conducting a binding assay on an absorbent carrier material | |
| EP0824697B1 (en) | One step immunochromatographic device and method of use | |
| US5846838A (en) | Opposable-element assay device employing conductive barrier | |
| EP0733210B1 (en) | Assay device with a barrier for regulating reagent application | |
| US4839297A (en) | Test carrier and method for the analytical determination of a component of a body fluid | |
| EP1376130B1 (en) | Assay device with two opposable members | |
| US5879951A (en) | Opposable-element assay device employing unidirectional flow | |
| US6017767A (en) | Assay device | |
| US5110550A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
| EP0306772B1 (en) | Lateral flow chromatographic binding assay device | |
| CA2005564C (en) | Test carrier for the analytical investigation of a sample liquid with the help of a specific binding reaction of two bioaffine binding partners and a corresponding test process | |
| US4956302A (en) | Lateral flow chromatographic binding assay device | |
| EP1046913B1 (en) | Immunochromatographic assay | |
| EP0888547B1 (en) | Immunoassay with whole blood | |
| WO1998022824A1 (en) | Immunochromatography test strips | |
| EP1061368B1 (en) | Agglutination assay method in binder medium | |
| EP1069433A2 (en) | Agglutination assay method in porous medium layer | |
| EP0427534B1 (en) | Improvement in non-instrumental diagnostic assay distance determination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |